Effect of estrogen and progesterone on L-dopa induced dyskinesia in MPTP-treated monkeys

Neurosci Lett. 1992 Jan 20;135(1):129-32. doi: 10.1016/0304-3940(92)90152-w.

Abstract

A group of 4 cynomolgus monkeys was rendered parkinsonian by the toxin MPTP and then treated daily with L-DOPA until all animals developed dyskinesia. At this point, 17 beta-estradiol, 17 alpha-estradiol and progesterone were injected s.c. singly or in combination for 7 days and the treatment with L-DOPA reinstituted. Our results show that the pretreatment with 17 beta-estradiol reduced the dyskinetic effect without altering the therapeutic response to L-DOPA, while 17 alpha-estradiol did not alter the dyskinetic and the antiparkinsonian effect.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine*
  • Animals
  • Drug Therapy, Combination
  • Dyskinesia, Drug-Induced / physiopathology
  • Dyskinesia, Drug-Induced / prevention & control*
  • Estradiol / therapeutic use*
  • Female
  • Levodopa / therapeutic use
  • Levodopa / toxicity*
  • Macaca fascicularis
  • Parkinson Disease, Secondary / drug therapy*
  • Progesterone / therapeutic use*

Substances

  • Levodopa
  • Progesterone
  • Estradiol
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine